Search results
Bristol-Myers Squibb Insiders Sold US$1.1m Of Shares Suggesting Hesitancy
Simply Wall St. via Yahoo Finance· 2 hours agoTransactions At Bristol-Myers Squibb Over the last year, we can see that the biggest insider sale...
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Benzinga via AOL· 22 hours agoOn Thursday, the FDA approved Geron Corporation's (NASDAQ:GERN) Rytelo (imetelstat) for adult...
Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
Insider Monkey via Yahoo Finance· 3 days agoWe recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co (NYSE...
Geron stock steady as analysts maintain 'buy' rating with $10 target By Investing.com
Investing.com· 19 hours agoThe endorsement comes after Geron's drug Rytelo (imetelstat) received approval for the treatment of...
Smart Money Is Betting Big In BMY Options - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 17 hours agoBut when something this big happens with BMY, it often means somebody knows something is about to happen. So how do we know what these investors just did? Today, Benzinga 's
Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago
Simply Wall St. via Yahoo Finance· 4 days agoBut if you buy individual stocks, you can do both better or worse than that. For example, the...
California State Teachers Retirement System Purchases 60,431 Shares of Bristol-Myers Squibb (NYSE...
ETF DAILY NEWS· 5 days agoCalifornia State Teachers Retirement System grew its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.8% during the fourth quarter, according ...
Geron surges after winning first US FDA approval for blood disorder drug By Reuters
Investing.com· 1 day agoThe health regulator's nod allows the injectable drug, branded as Rytelo, to be used for treating...
I-Mab and Bristol Myers team up for cancer drug trial By Investing.com
Investing.com· 3 days ago(NASDAQ: IMAB), a biotechnology firm specializing in cancer immunotherapies, has announced a...
Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 5 days agoBristol Myers Squibb & Co BMY announced on Saturday (June 1) results from the Phase 3 KRYSTAL-12...